Implementation Science Grants

The Leukaemia Foundation are committed to investing in research that improves the lives of Australians living with blood cancer.

The Leukaemia Foundation’s Implementation Science Grants are designed to accelerate the adoption of proven, evidence-based innovations across the health system and address persistent gaps in care experienced by people living with blood cancer.

Implementation science plays a critical role in ensuring innovations, guidelines, and research breakthroughs do not remain on paper, but are translated into consistent, high-quality care across the healthcare system. Through these funded projects, we aim to change the conditions of care, not simply generate new interventions – ensuring that people with blood cancer benefit from the best available evidence everywhere, every time.

Implementation Science Grants:

Value: up to $100,000 per grant, applicants may be asked to scale their projects accordingly

Duration: Up to 2 years

Objectives:

Projects must:

• Address known challenges faced by people living with blood cancer
• Address complex problem(s) in the Australian health system
• Translate evidence-based interventions, guidelines, pathways, or models into routine practice
• Promote equity, inclusion and cultural safety

Focus: Projects can focus on any known gaps or challenges faced by people living with blood cancer in Australia.

Examples can include epidemiological modelling of disease, PRO, PROM and PREM collection, addressing disparities among underserved populations, survivorship care research, improving access to treatment and therapies, improving quality of care, embedding genomic testing into routine care, integration of psychosocial care into routine practice, etc.

Eligibility

Applicants must:

• Hold academic, clinical or research appointment at an eligible institution (Australian university, hospital, health service, or research institution) with institutional support for the duration of the project
• Have demonstrated expertise in implementation science, health services research, or translational research and clinical or research experience in haematology or oncology
• Have knowledge of implementation science, including use of established frameworks (e.g. Proctor’s outcomes, RE-AIM, CFIR, TDF). If the Chief Investigator (CI) does not have this expertise, the project must include an Associate Investigator (AI) who does.
• Have experience of collaboration with clinicians, health services management, policy partners, and consumers
• Demonstrate the ability to lead a multidisciplinary project, manage timelines and budgets, and work effectively with clinical services.
• Show commitment to cultural safety and equity
• Have the ability to secure ethics approval and comply with national research governance standards

Projects must:

• Clearly specify a complex, real-world challenge in blood cancer care
• Apply at least one core implementation science framework (e.g. Proctor’s outcomes, RE-AIM, CFIR, TDF)
• Aim to implement an evidence-based blood cancer intervention, guideline, pathway, tool, measure or model of care; OR
• Adapt an existing evidence-based practice for a new population or setting; OR
• Evaluate implementation strategies for scaling or sustaining an existing service
• Include engagement with consumers and relevant stakeholders (e.g. patients, carers, policy makers, clinicians, etc.)
• Clearly describe implementation strategies to be used and a plan to measure outcomes and a plan for scalability and sustainability

Basic science, laboratory-based translational research, or projects focused on testing intervention efficacy only are out of scope and will not be considered.

Key Dates

Applications open: 19 January 2026 

Applications close: 6 March 2026  

Applicants notified and project commencement:  from May 2026 

How to apply

For further information on the Implementation Science Grants, please view the Implementation Science Guideline document provided below.

For any queries about the Implementation Science Grants, please contact our research team via email at [email protected].